A-1331852 |
Inhibitor of BCL2L1
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| BCL2L1 |
|
|
Inhibitor
up to 100 nM
Selectivity
In Vitro Selectivity Assessment
Potency Assay Off-Target:
TR-FRET
Selectivity Assessment Description:
Bcl-W 4 nM (Ki), Bcl-2 6 nM (Ki), Mcl-1 142 nM (Ki)
In Cell Selectivity Assessment
Selectivity Assessment Description:
RSA;11 EC50 >5000 nM
Potency Cellular
In Vitro
BCL2L1
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? No
In Vivo Validations
Mouse, Rat
Dose: 5-30 mg/Kg
Route of delivery:
Oral
Plasma half life:
3.9 (R), 2.4 (M) h
Systemic clearance:
0.08 (R), 0.22 (M) L/h/Kg
Reference: --
Chemical Information
| Molecular Formula | C38H38N6O3S |
| SMILEs | Cc1c(-c2ccc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)cnn1CC12CC3CC(CC(C3)C1)C2 |
| InChI | InChI=1S/C38H38N6O3S/c1-22-29(19-39-44(22)21-38-16-23-13-24(17-38)15-25(14-23)18-38)27-9-10-33(41-34(27)36(46)47)43-12-11-26-5-4-6-28(30(26)20-43)35(45)42-37-40-31-7-2-3-8-32(31)48-37/h2-10,19,23-25H,11-18,20-21H2,1H3,(H,46,47)(H,40,42,45) |
| Molecular weight | 658.27 Da |
| AlogP | 7.59282 |
| HBond acceptors | 9 |
| HBond donors | 2 |
| Atoms | 86 |
Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the portal.